SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950123-10-058674
Filing Date
2010-06-16
Accepted
2010-06-16 17:18:39
Documents
2
Period of Report
2010-08-01

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT c02454pre14a.htm PRE 14A 585004
2 GRAPHIC c02454c0245400.gif GRAPHIC 4199
  Complete submission text file 0000950123-10-058674.txt   592378
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-24274 | Film No.: 10901322
SIC: 2836 Biological Products, (No Diagnostic Substances)